CC | Ticker Profile - Titan Protect

The Chemours Company

Basic Materials · Specialty Chemicals · NYQ

$20.50

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$3.4B

Total market value of the company

Trailing P/E

N/A

Forward P/E

9.95

Based on estimated future earnings — lower means cheaper

Rev Growth

+1.0%

Year-over-year revenue change

Profit Margin

-7.0%

How much profit the company keeps from each dollar of revenue

ROE

-103.0%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$26.00

+27% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 9 analysts covering this stock

About The Chemours Company

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

https://www.chemours.com

Country: United States Employees: 5,700 Industry: Specialty Chemicals

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.274

Positive but modest risk-adjusted returns

Kelly Fraction

0.0157

Marginal edge — very small allocation suggested

Calmar Ratio

-0.033

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-2.0%

Historical annualised return based on price data

Max Drawdown

-61.3%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.46

Moves slightly more than the broader market

52W High

$28.67

28% below the year high

52W Low

$9.13

125% above the year low

Avg Volume

3,127,840

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.2

Days it would take all short sellers to cover — higher means more crowded

Short % Float

8.9%

Moderate short interest

Div Yield

156.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$-2.73

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

2,033.80

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.82

Healthy liquidity position

Quick Ratio

0.82

Like current ratio but excludes inventory — stricter test

Gross Margin

15.2%

Revenue left after cost of goods — higher means pricing power

Operating Margin

3.0%

Profit from core operations before interest and tax

Free Cash Flow

$216M

Positive — the business generates more cash than it spends

Revenue (TTM)

$5.8B

Total revenue over the last 12 months

Net Income

$-410,000,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$30.00

Target Median

$26.00

Target Low

$21.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
8 May2026	Kevin Hern	Republican	exchange	15K–50K
8 May2026	Kevin Hern	Republican	exchange	15K–50K
7 Feb2025	Tim Walberg	Republican	buy	15K–50K
6 Apr2026	Josh Gottheimer	Democrat	buy	1K–15K
2026-04-13	Ro Khanna	Democrat	Purchase	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go